MedTrace Logo

Metabolic and QOL Effects of GH Treatment in Patients With TBI and AGHD

NCT02988687 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2023-03-06

No results posted yet for this study

Summary

This PILOT, NON-INTERVENTIONAL STUDY will follow patients about to start rhGH for a period of six months and collect valuable pilot data to evaluate feasibility of a larger study and treatment tolerability and compliance. The effect of rhGH on cognitive function, depression, fatigue, sleep quality, and QOL will also be collected. This exploratory study will also provide important information about recruitment and AGHD screening procedures in military settings.

Conditions

  • Adult-Onset Growth Hormone Deficiency

Sponsors & Collaborators

  • Garcia, Jose M., MD, PhD

    lead INDIV

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2022-10-31
Completion
2022-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02988687 on ClinicalTrials.gov